Doxepin recalls

The FDA has published 2 recalls involving Doxepin since 2014. The latest was reported on 13 Aug 2025. Most were for labeling errors. Alembic Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2014
Last 12 months0reported
Class I00% of total
Ongoing1latest 13 Aug 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why doxepin is recalled

By year

Ongoing doxepin recalls

1 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDoxepin Hydrochloride Capsules, USP, 10 mg recalledDoxepin HydrochlorideAlembic PharmaceuticalsNitrosamine ImpurityNationwide

All doxepin recalls, newest first

2 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDoxepin Hydrochloride Capsules, USP, 10 mg recalledDoxepin HydrochlorideAlembic PharmaceuticalsNitrosamine ImpurityNationwide
DrugCLASS IIDoxepin HCL Capsule, 150 mg recalled by Aidapak ServicesAidapak ServicesLabeling Errors4 states

Should you stop taking Doxepin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.